Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | SELL | P14151 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL846024 | 0.81 | HCAR2 (0.50) | HCAR2KDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL9504528 | 0.79 | HCAR2 (0.48) | HCAR2KDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL6052889 | 0.79 | HCAR2 (0.48) | HCAR2KDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL30668508 | 0.79 | HCAR2 (0.48) | HCAR2KDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL14803342 | 0.79 | KDM4E (0.52) | KDM4EALDH1A1HSD17B10CA12CA1 | |
| SCHEMBL17703486 | 0.79 | KDM4E (0.55) | KDM4EALDH1A1HSD17B10CA12CA1 | |
| SCHEMBL27751624 | 0.78 | KDM4E (0.50) | HCAR2KDM4EALDH1A1HSD17B10CA12 | |
| SCHEMBL12845747 | 0.78 | HCAR2 (0.47) | HCAR2KDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL7356328 | 0.78 | KDM4E (0.47) | HCAR2KDM4EALDH1A1HSD17B10MAPT | |
| SCHEMBL10200753 | 0.78 | TPMT (0.48) | HCAR2KDM4EALDH1A1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111393290-B | Preparation method of 3,4, 5-trimethylhydroquinone dialkanoate | 万华化学集团股份有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-112156645-B | Composite biological enzyme deodorant and preparation method thereof | 柳州市宝净科技有限公司 | 2021-04-27 | — | — | CN | claimed |
| CN-112156645-A | Composite biological enzyme deodorant and preparation method thereof | 柳州市宝净科技有限公司 | 2021-01-01 | — | — | CN | claimed |
| CN-111393290-A | Preparation method of 3,4, 5-trimethylhydroquinone dialkanoate | 万华化学集团股份有限公司 | 2020-07-10 | — | — | CN | claimed |
| US-20090211346-A1 | Methods for Detecting Alzheimer's Disease | BG MEDICINE, INC. | 2009-08-27 | — | — | US | claimed |
| EP-1869474-A1 | METHODS FOR DETECTING ALZHEIMER'S DISEASE | BG Medicine, Inc. (US) | 2007-12-26 | — | — | EP | claimed |
| WO-2006099377-A1 | METHODS FOR DETECTING ALZHEIMER'S DISEASE | BG MEDICINE, INC. (US) | 2006-09-21 | — | — | WO | claimed |
| US-20260007672-A1 | INHIBITORS OF MPTP | NRG THERAPEUTICS LTD (GB) | 2026-01-08 | — | — | US | disclosed |
| US-12491185-B2 | Inhibitors of mPTP | NRG THERAPEUTICS LTD (GB) | 2025-12-09 | — | — | US | disclosed |
| EP-4652162-A1 | INHIBITORS OF MPTP | NRG Therapeutics LTD (GB) | 2025-11-26 | — | — | EP | disclosed |
| US-20250177397-A1 | INHIBITORS OF MPTP | NRG THERAPEUTICS LTD (GB) | 2025-06-05 | — | — | US | disclosed |
| WO-2024153946-A1 | INHIBITORS OF MPTP | NRG THERAPEUTICS LTD (GB) | 2024-07-25 | — | — | WO | disclosed |
| CN-111393290-B | Preparation method of 3,4, 5-trimethylhydroquinone dialkanoate | 万华化学集团股份有限公司 | 2023-03-24 | — | — | CN | disclosed |
| US-8404465-B2 | Biological synthesis of 6-aminocaproic acid from carbohydrate feedstocks | CELEXION, LLC (US) | 2013-03-26 | — | — | US | disclosed |
| US-20130017593-A1 | Biological Synthesis of Difunctional Hexanes and Pentanes from Carbohydrate Feedstocks | CELEXION, LLC (US) | 2013-01-17 | — | — | US | disclosed |
| US-20120301950-A1 | BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL HEXANES AND PENTANES FROM CARBOHYDRATE FEEDSTOCKS | CELEXION, LLC | 2012-11-29 | — | — | US | disclosed |
| US-8206986-B2 | Methods for detecting Alzheimer's disease | BG MEDICINE, INC. (US) | 2012-06-26 | — | — | US | disclosed |
| US-20090211346-A1 | Methods for Detecting Alzheimer's Disease | BG MEDICINE, INC. | 2009-08-27 | — | — | US | disclosed |
| EP-1869474-A1 | METHODS FOR DETECTING ALZHEIMER'S DISEASE | BG Medicine, Inc. (US) | 2007-12-26 | — | — | EP | disclosed |
| WO-2006099377-A1 | METHODS FOR DETECTING ALZHEIMER'S DISEASE | BG MEDICINE, INC. (US) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12491185-B2 | Inhibitors of mPTP | PARK7, PINK1, SNCA | HCAR2 1506/4885KDM4E 2432/4885ALDH1A1 415/4885 |
| US-20250177397-A1 | INHIBITORS OF MPTP | PARK7, PINK1, SNCA | HCAR2 1506/4885KDM4E 2432/4885ALDH1A1 415/4885 |
| US-20260007672-A1 | INHIBITORS OF MPTP | PARK7, SNCA, CYC1 | HCAR2 713/4885KDM4E 3133/4885ALDH1A1 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.